NEUPRO transdermal patch medication leaflet

N04BC09 rotigotine • Nervous system | Dopaminergic agents | Dopamine agonists


Rotigotine is a medication used to treat Parkinson's disease and restless legs syndrome. This medicine helps relieve motor symptoms such as tremor, stiffness, and movement difficulties by stimulating dopamine receptors in the brain. Rotigotine contributes to improving the quality of life for patients with these neurological conditions.

Rotigotine is usually administered as a transdermal patch, applied to the skin once a day. The dose is adjusted by the doctor based on the patient's response and the severity of symptoms. It is important to follow the application instructions and not to stop the treatment without your doctor's approval.

Side effects of rotigotine may include skin reactions, nausea, dizziness, drowsiness, or insomnia. In rare cases, more serious reactions may occur, such as behavioral disorders or hallucinations. If you notice any unusual symptoms, contact your doctor immediately.

Rotigotine is a modern medicine that provides an effective option for controlling the symptoms of Parkinson's disease and restless legs syndrome. Regular monitoring and communication with your doctor are essential for the safety and effectiveness of the treatment. Inform your doctor about any other medications or supplements you are taking.

General data about NEUPRO

Substance: rotigotine

Date of last drug list: 01-07-2015

Commercial code: W61548001

Pharmaceutical form: transdermal patch

Quantity: 1

Product type: original

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Concentrations available for rotigotine

1mg/24h, 2mg/24h, 3mg/24h, 4mg/24h, 6mg/24h, 8mg/24h